Unknown OBSERVATIONAL NCT06220994

the Gut Microbiome and Metabolomics in Chronic Lower extreMities Threatening Ischemia (MMM)

The Gut Microbiome and Metabolomics Among Chronic Lower Extremities Threatening Ischemia Patients in China - a Prospective Observational Study

Sponsor: Beijing Tsinghua Chang Gung Hospital

Conditions Chronic Limb-threatening Ischemia Microtia

Updated 4 times since 2024 Last updated: Jan 14, 2024 Started: Nov 15, 2021 Primary completion: May 15, 2025 Completion: May 15, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06220994, this observational or N/A phase trial focuses on Chronic Limb-threatening Ischemia and Microtia and remains ongoing. Sponsored by Beijing Tsinghua Chang Gung Hospital, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Jun 2025 — Present [monthly]

Unknown

Status: Enrolling By Invitation → Unknown
Sep 2024 — Jun 2025 [monthly]

Enrolling By Invitation
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation
Feb 2024 — Jul 2024 [monthly]

Enrolling By Invitation

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Tsinghua Chang Gung Hospital

Data source: Beijing Tsinghua Chang Gung Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China